TP53 and neoplasm: Consistent with this, mice expressing mutant alleles of p53 that are competent for initiating the G1/S checkpoint have a much longer tumor latency and develop a broader spectrum of non-lymphoma type tumors than p53 alone (Liu et al., 2004; Barboza et al., 2006).